The mission of our clinical research is to foster discoveries in the novel therapies of inflammatory bowel diseases, gastrointestinal and pancreatic cancer, hepatitis, and other gastrointestinal disorders. Our doctors are committed to providing the best care and management of diseases while testing cutting-edge therapies.

Back to full list of clinical trials

Ongoing clinical trials for non-alcoholic fatty liver disease: Actively recruiting


Non-Alcoholic Fatty Liver Disease

Study title:

Non-Alcoholic Fatty Liver Disease Registry

Description of study:

This registry follows patients and family members with suspected or established non-alcoholic fatty liver disease. The purpose of this study is to identify non-invasive ways to diagnosis fatty liver disease as well as attempt to understand the causes of fatty liver disease.

Basic eligibility criteria:

Any patient with either abnormal liver function tests or fatty liver seen on ultrasound, CT scan or MRI is eligible.

Principal Investigator:

Kathleen Corey, MD, MPH


Kyle Malecki; 617-726-3670